BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 10843991)

  • 1. The protein-tyrosine phosphatase SHP-2 is required during angiotensin II-mediated activation of cyclin D1 promoter in CHO-AT1A cells.
    Guillemot L; Levy A; Zhao ZJ; Bereziat G; Rothhut B
    J Biol Chem; 2000 Aug; 275(34):26349-58. PubMed ID: 10843991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin II-induced transcriptional activation of the cyclin D1 gene is mediated by Egr-1 in CHO-AT(1A) cells.
    Guillemot L; Levy A; Raymondjean M; Rothhut B
    J Biol Chem; 2001 Oct; 276(42):39394-403. PubMed ID: 11502738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of calcium-sensitive tyrosine kinase Pyk2 by angiotensin II in endothelial cells. Roles of Yes tyrosine kinase and tyrosine phosphatase SHP-2.
    Tang H; Zhao ZJ; Landon EJ; Inagami T
    J Biol Chem; 2000 Mar; 275(12):8389-96. PubMed ID: 10722671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. sst2 somatostatin receptor mediates cell cycle arrest and induction of p27(Kip1). Evidence for the role of SHP-1.
    Pagès P; Benali N; Saint-Laurent N; Estève JP; Schally AV; Tkaczuk J; Vaysse N; Susini C; Buscail L
    J Biol Chem; 1999 May; 274(21):15186-93. PubMed ID: 10329727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatostatin activation of mitogen-activated protein kinase via somatostatin receptor 1 (SSTR1).
    Florio T; Yao H; Carey KD; Dillon TJ; Stork PJ
    Mol Endocrinol; 1999 Jan; 13(1):24-37. PubMed ID: 9892010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of angiotensin II-induced JAK2 tyrosine phosphorylation: roles of SHP-1 and SHP-2.
    Marrero MB; Venema VJ; Ju H; Eaton DC; Venema RC
    Am J Physiol; 1998 Nov; 275(5):C1216-23. PubMed ID: 9814969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin II type 2 receptor inhibits epidermal growth factor receptor transactivation by increasing association of SHP-1 tyrosine phosphatase.
    Shibasaki Y; Matsubara H; Nozawa Y; Mori Y; Masaki H; Kosaki A; Tsutsumi Y; Uchiyama Y; Fujiyama S; Nose A; Iba O; Tateishi E; Hasegawa T; Horiuchi M; Nahmias C; Iwasaka T
    Hypertension; 2001 Sep; 38(3):367-72. PubMed ID: 11566906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin II type 2 receptors mediate inhibition of mitogen-activated protein kinase cascade and functional activation of SHP-1 tyrosine phosphatase.
    Bedecs K; Elbaz N; Sutren M; Masson M; Susini C; Strosberg AD; Nahmias C
    Biochem J; 1997 Jul; 325 ( Pt 2)(Pt 2):449-54. PubMed ID: 9230127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. sst2 Somatostatin receptor inhibits cell proliferation through Ras-, Rap1-, and B-Raf-dependent ERK2 activation.
    Lahlou H; Saint-Laurent N; Estève JP; Eychène A; Pradayrol L; Pyronnet S; Susini C
    J Biol Chem; 2003 Oct; 278(41):39356-71. PubMed ID: 12878607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pivotal role of tyrosine phosphatase SHP-1 in AT2 receptor-mediated apoptosis in rat fetal vascular smooth muscle cell.
    Cui T; Nakagami H; Iwai M; Takeda Y; Shiuchi T; Daviet L; Nahmias C; Horiuchi M
    Cardiovasc Res; 2001 Mar; 49(4):863-71. PubMed ID: 11230986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective down-regulation of angiotensin II receptor type 1A signaling by protein tyrosine phosphatase SHP-2 in vascular smooth muscle cells.
    Doan T; Farmer P; Cooney T; Ali MS
    Cell Signal; 2004 Mar; 16(3):301-11. PubMed ID: 14687660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Src homology region 2 (SH2) domain-containing phosphatase-1 dephosphorylates B cell linker protein/SH2 domain leukocyte protein of 65 kDa and selectively regulates c-Jun NH2-terminal kinase activation in B cells.
    Mizuno K; Tagawa Y; Mitomo K; Arimura Y; Hatano N; Katagiri T; Ogimoto M; Yakura H
    J Immunol; 2000 Aug; 165(3):1344-51. PubMed ID: 10903736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SH2 domain containing protein tyrosine phosphatase 2 regulates concanavalin A-dependent secretion and activation of matrix metalloproteinase 2 via the extracellular signal-regulated kinase and p38 pathways.
    Ruhul Amin AR; Oo ML; Senga T; Suzuki N; Feng GS; Hamaguchi M
    Cancer Res; 2003 Oct; 63(19):6334-9. PubMed ID: 14559821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The tyrosine phosphatase SHP-2 is required for mediating phosphatidylinositol 3-kinase/Akt activation by growth factors.
    Wu CJ; O'Rourke DM; Feng GS; Johnson GR; Wang Q; Greene MI
    Oncogene; 2001 Sep; 20(42):6018-25. PubMed ID: 11593409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin II activation of cyclin D1-dependent kinase activity.
    Watanabe G; Lee RJ; Albanese C; Rainey WE; Batlle D; Pestell RG
    J Biol Chem; 1996 Sep; 271(37):22570-7. PubMed ID: 8798425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of the Src homology 2-containing tyrosine phosphatase SHP-2 in growth hormone signaling.
    Kim SO; Jiang J; Yi W; Feng GS; Frank SJ
    J Biol Chem; 1998 Jan; 273(4):2344-54. PubMed ID: 9442080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorylation of tyrosine 319 of the angiotensin II type 1 receptor mediates angiotensin II-induced trans-activation of the epidermal growth factor receptor.
    Seta K; Sadoshima J
    J Biol Chem; 2003 Mar; 278(11):9019-26. PubMed ID: 12522132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of the complex formation of SHPS-1 with SHP-2 in insulin-stimulated mitogen-activated protein kinase activation.
    Takada T; Matozaki T; Takeda H; Fukunaga K; Noguchi T; Fujioka Y; Okazaki I; Tsuda M; Yamao T; Ochi F; Kasuga M
    J Biol Chem; 1998 Apr; 273(15):9234-42. PubMed ID: 9535915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Divergent roles of SHP-2 in ERK activation by leptin receptors.
    Bjørbaek C; Buchholz RM; Davis SM; Bates SH; Pierroz DD; Gu H; Neel BG; Myers MG; Flier JS
    J Biol Chem; 2001 Feb; 276(7):4747-55. PubMed ID: 11085989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of angiotensin II type 2 receptor on tyrosine kinase Pyk2 and c-Jun NH2-terminal kinase via SHP-1 tyrosine phosphatase activity: evidence from vascular-targeted transgenic mice of AT2 receptor.
    Matsubara H; Shibasaki Y; Okigaki M; Mori Y; Masaki H; Kosaki A; Tsutsumi Y; Uchiyama Y; Fujiyama S; Nose A; Iba O; Tateishi E; Hasegawa T; Horiuchi M; Nahmias C; Iwasaka T
    Biochem Biophys Res Commun; 2001 Apr; 282(5):1085-91. PubMed ID: 11302725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.